Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Mar 2016 04:28 PM
RNS
Holding(s) in Company
07 Mar 2016 07:00 AM
RNS
Immune Design Collaboration and Licence Expanded
01 Mar 2016 11:04 AM
RNS
Total Voting Rights
01 Mar 2016 09:46 AM
RNS
Holding(s) in Company
01 Mar 2016 09:44 AM
RNS
Holding(s) in Company
01 Mar 2016 09:38 AM
RNS
Notice of Preliminary Results date: 28 April 2016
29 Feb 2016 12:16 PM
RNS
Director/PDMR Shareholding
26 Feb 2016 04:42 PM
RNS
Holding(s) in Company
25 Feb 2016 05:16 PM
RNS
Director/PDMR Shareholding
25 Feb 2016 02:46 PM
RNS
Holding(s) in Company
25 Feb 2016 02:45 PM
RNS
Director/PDMR Shareholding
25 Feb 2016 09:36 AM
RNS
Holding(s) in Company
23 Feb 2016 07:00 AM
RNS
Placing to raise £8.1 Million
16 Feb 2016 10:59 AM
RNS
Holding(s) in Company
11 Feb 2016 04:40 PM
RNS
Second Price Monitoring Extn
11 Feb 2016 04:35 PM
RNS
Price Monitoring Extension
02 Feb 2016 09:37 AM
RNS
Total Voting Rights
29 Jan 2016 07:00 AM
RNS
Initiation of Second CART Programme for Novartis
13 Jan 2016 07:00 AM
RNS
MHRA approval to manufacture in new facility
05 Jan 2016 07:00 AM
RNS
Directorate Change
04 Jan 2016 07:00 AM
RNS
Blocklisting Interim Review
04 Jan 2016 07:00 AM
RNS
Total Voting Rights
21 Dec 2015 02:11 PM
RNS
Total Voting Rights
15 Dec 2015 07:00 AM
RNS
Appointment of New Chairman
02 Dec 2015 11:14 AM
RNS
Total Voting Rights
30 Nov 2015 11:32 AM
RNS
Holding(s) in Company
20 Nov 2015 04:40 PM
RNS
Second Price Monitoring Extn
20 Nov 2015 04:35 PM
RNS
Price Monitoring Extension
18 Nov 2015 09:43 AM
RNS
OXB present at Jefferies Healthcare Conference
13 Nov 2015 04:35 PM
RNS
Price Monitoring Extension
04 Nov 2015 07:00 AM
RNS
Business Update
02 Nov 2015 07:00 AM
RNS
Total Voting Rights
28 Oct 2015 07:00 AM
RNS
GSK Exercises Option on OXB LentiVector Patents
01 Oct 2015 04:10 PM
RNS
Total Voting Rights
11 Sep 2015 04:35 PM
RNS
Price Monitoring Extension
01 Sep 2015 07:03 AM
RNS
Total Voting Rights
27 Aug 2015 07:00 AM
RNS
Interim Results
06 Aug 2015 05:16 PM
RNS
Holding(s) in Company
06 Aug 2015 07:00 AM
RNS
Notice of Interim Results
03 Aug 2015 07:00 AM
RNS
Total Voting Rights
01 Jul 2015 08:54 AM
RNS
Director/PDMR Shareholding
01 Jul 2015 07:00 AM
RNS
Blocklisting Interim Review
01 Jul 2015 07:00 AM
RNS
Total Voting Rights
30 Jun 2015 09:13 AM
RNS
Director/PDMR Shareholding
25 Jun 2015 03:40 PM
RNS
Oxford BioMedica Block listing Application
23 Jun 2015 12:00 PM
RNS
OXB to present at JMP Securities
19 Jun 2015 10:26 AM
RNS
Director/PDMR Shareholding
17 Jun 2015 01:21 PM
RNS
Director/PDMR Shareholding
16 Jun 2015 02:03 PM
RNS
Director/PDMR Shareholding
15 Jun 2015 11:23 AM
RNS
Director/PDMR Shareholding

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings